| 436 |
Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries |
Gina Mennen |
BY-SA |
1880: Decreased, ALDH1A (RALDH) enzyme activity
|
1970: transposition of the great arteries
|
|
|
| 437 |
Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity |
Baki Sadi |
BY-SA |
105: Inhibition, Mitochondrial Electron Transport Chain Complexes
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.99 |
| 438 |
reactive oxygen species generation leading to increased cardiovascular morbidity and mortality |
Yu Yang |
All rights reserved |
None
|
None
|
|
|
| 439 |
Activation of the AhR leading to metastatic breast cancer |
Louise Benoit |
BY-SA |
18: Activation, AhR
|
1982: metastatic breast cancer
|
Under Review |
1.105 |
| 440 |
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia |
Kalyan Gayen |
All rights reserved |
1046: Suppression, Estrogen receptor (ER) activity
|
2 AOs
|
Under Development |
1.104 |
| 441 |
Ionizing radiation-induced DNA damage leads to microcephaly via apoptosis and premature cell differentiation |
Olivier ARMANT |
BY-SA |
1686: Deposition of Energy
|
1978: Increase risk, microcephaly
|
|
|
| 442 |
Binding to voltage gate sodium channels during development leads to cognitive impairment |
Iris Mangas |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
WPHA/WNT Endorsed |
1.91 |
| 443 |
DNA damage and mutations leading to Metastatic Breast Cancer |
Usha Adiga |
BY-SA |
1669: Increased, DNA damage and mutation
|
1982: metastatic breast cancer
|
Under Development |
1.103 |
| 444 |
Ionizing radiation leads to reduced reproduction in Eisenia fetida via reduced spermatogenesis and cocoon hatchability |
Deborah Oughton |
BY-SA |
3 MIEs
|
360: Decrease, Population growth rate
|
|
|
| 445 |
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction |
John Hoang |
BY-SA |
1065: Activation, estrogen receptor alpha
|
1991: Impaired, Reproduction
|
|
|
| 446 |
PM-related Adverse outcome pathway frameworks on various systems |
Tianyu Li |
BY-SA |
None
|
None
|
|
|
| 447 |
Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways |
Yann GUEGUEN |
BY-SA |
None
|
759: Increased, Kidney Failure
|
|
|
| 448 |
ROS, inflammation, and activation of nAChR lead to increased incidence of cardiovascular morbidity and mortality |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 449 |
Ceramide synthase inhibition leading to neural tube defects |
Lola Bajard |
BY-SA |
2023: Inhibition of Ceramide Synthase
|
1561: Neural tube defects
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 452 |
Adverse outcome pathway of PM-induced respiratory toxicity |
li qing |
BY-SA |
2007: Non-coding RNA expression profile alteration
|
2008: Chronic obstructive pulmonary disease
|
|
|
| 453 |
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 454 |
PM2.5-related AOP frameworks on liver diseases |
Zhou Du |
BY-SA |
None
|
None
|
|
|
| 455 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
2 AOs
|
WPHA/WNT Endorsed |
1.27 |
| 456 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.27 |
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 459 |
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 460 |
Antagonism of Smoothened receptor leading to orofacial clefting |
Jacob Reynolds |
BY-SA |
2027: Antagonism, Smoothened receptor
|
2042: Increase, Orofacial clefting
|
Under Review |
1.101 |